Cargando…

Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications

Adrenocortical carcinoma (ACC) is a rare endocrine malignancy and treatment of advanced disease is challenging. Clinical trials with multi-tyrosine kinase inhibitors in the past have yielded disappointing results. Here, we investigated fibroblast growth factor (FGF) receptors and their pathways in a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sbiera, Iuliu, Kircher, Stefan, Altieri, Barbara, Lenz, Kerstin, Hantel, Constanze, Fassnacht, Martin, Sbiera, Silviu, Kroiss, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699171/ https://www.ncbi.nlm.nih.gov/pubmed/34956100 http://dx.doi.org/10.3389/fendo.2021.795116

Ejemplares similares

Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues?
por: Sbiera, Iuliu, et al.
Publicado: (2021)

FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma
por: Tamburello, Mariangela, et al.
Publicado: (2022)

Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma
por: Liang, Raimunde, et al.
Publicado: (2020)

Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma
por: Landwehr, Laura-Sophie, et al.
Publicado: (2020)

SAT-354 Characterization of Cell Death Induced by SOAT1 Inhibition in Adrenocortical Carcinoma Cells
por: Weigand, Isabel, et al.
Publicado: (2019)

Sunitinib Inhibits Cell Proliferation and Alters Steroidogenesis by Down-Regulation of HSD3B2 in Adrenocortical Carcinoma Cells
por: Kroiss, Matthias, et al.
Publicado: (2011)

FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale
por: Adam, Pia, et al.
Publicado: (2021)

Case Report: Consecutive Adrenal Cushing’s Syndrome and Cushing’s Disease in a Patient With Somatic CTNNB1, USP8, and NR3C1 Mutations
por: Detomas, Mario, et al.
Publicado: (2021)

Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma
por: Chifu, Irina, et al.
Publicado: (2020)

Steroid profiling using liquid chromatography mass spectrometry during adrenal vein sampling in patients with primary bilateral macronodular adrenocortical hyperplasia
por: Zhang, Ru, et al.
Publicado: (2022)

CYP2W1 Is Highly Expressed in Adrenal Glands and Is Positively Associated with the Response to Mitotane in Adrenocortical Carcinoma
por: Ronchi, Cristina L., et al.
Publicado: (2014)

High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancer
por: Eckhardt, Carolin, et al.
Publicado: (2021)

Low SGK1 Expression in Human Adrenocortical Tumors Is Associated with ACTH-Independent Glucocorticoid Secretion and Poor Prognosis
por: Ronchi, Cristina L., et al.
Publicado: (2012)

Identifying New Potential Biomarkers in Adrenocortical Tumors Based on mRNA Expression Data Using Machine Learning
por: Marquardt, André, et al.
Publicado: (2021)

Single Nucleotide Polymorphism Array Profiling of Adrenocortical Tumors - Evidence for an Adenoma Carcinoma Sequence?
por: Ronchi, Cristina L., et al.
Publicado: (2013)

Circulating microRNA Expression in Cushing’s Syndrome
por: Vetrivel, Sharmilee, et al.
Publicado: (2021)

PKA Cα subunit mutation triggers caspase-dependent RIIβ subunit degradation via Ser(114) phosphorylation
por: Weigand, Isabel, et al.
Publicado: (2021)

SUN-350 Sterol-O-Acyl Transferase 1 Protein Expression Alone Is Not Sufficient to Predict Response to Mitotane Treatment in Adrenocortical Carcinoma
por: Weigand, Isabel, et al.
Publicado: (2019)

Early Postoperative Circulating miR-483-5p Is a Prognosis Marker for Adrenocortical Cancer
por: Oreglia, Maurine, et al.
Publicado: (2020)

Livin/BIRC7 expression as malignancy marker in adrenocortical tumors
por: Altieri, Barbara, et al.
Publicado: (2016)

MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma
por: Detomas, Mario, et al.
Publicado: (2022)

Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors
por: Heck, Dorothee, et al.
Publicado: (2015)

Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT Study
por: Altieri, Barbara, et al.
Publicado: (2020)

Active steroid hormone synthesis renders adrenocortical cells highly susceptible to type II ferroptosis induction
por: Weigand, Isabel, et al.
Publicado: (2020)

SUN-211 Active Steroid Hormone Synthesis Renders Adrenocortical Cells Highly Susceptible to Type II Ferroptosis Induction
por: Weigand, Isabel, et al.
Publicado: (2020)

Heat Shock Protein 90 as a Prognostic Marker and Therapeutic Target for Adrenocortical Carcinoma
por: Siebert, Claudia, et al.
Publicado: (2019)

Differential expression of the protein kinase A subunits in normal adrenal glands and adrenocortical adenomas
por: Weigand, Isabel, et al.
Publicado: (2017)

Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC
por: Doghman-Bouguerra, Mabrouka, et al.
Publicado: (2020)

SUN-LB22 PLK1 as a New Treatment Target for Adrenocortical Carcinoma
por: Smith, Gabrielle, et al.
Publicado: (2020)

Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study
por: Remde, Hanna, et al.
Publicado: (2023)

Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer
por: Rossini, Elisa, et al.
Publicado: (2021)

The New Genetic Landscape of Cushing’s Disease: Deubiquitinases in the Spotlight
por: Sbiera, Silviu, et al.
Publicado: (2019)

SOAT1: A Suitable Target for Therapy in High-Grade Astrocytic Glioma?
por: Löhr, Mario, et al.
Publicado: (2022)

Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma
por: Kimpel, Otilia, et al.
Publicado: (2022)

An update on adrenocortical cell lines of human origin
por: Sigala, Sandra, et al.
Publicado: (2022)

Metabolic heterogeneity in adrenocortical carcinoma impacts patient outcomes
por: Wang, Qian, et al.
Publicado: (2023)

Prognostic Role of Targeted Methylation Analysis in Paraffin-embedded Samples of Adrenocortical Carcinoma
por: Lippert, Juliane, et al.
Publicado: (2022)

Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management
por: Lenschow, Christina, et al.
Publicado: (2021)

Pediatric adrenocortical carcinoma
por: Ilanchezhian, Maran, et al.
Publicado: (2022)

Investigating the Role of Cholesterol and Lipid Trafficking in Mitotane Resistance in Adrenocortical Carcinoma
por: Warde, Kate, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mg3n1qtbcv6gb1h8ivhf7aln20